Wesley Burwell
Personalreferent bei BOLT BIOTHERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Wesley Burwell
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 23 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Wesley Burwell
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Founder | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Founder | |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| NTG NORDIC TRANSPORT GROUP A/S | Trucking | Corporate Officer/Principal | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin | |
| University of Mumbai | College/University | Undergraduate Degree Undergraduate Degree | |
| The State University of New York | College/University | Doctorate Degree Doctorate Degree | |
| Danmarks Farmaceutiske Universitet | College/University | Doctorate Degree | |
7TM A/S
 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Founder | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor | |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Corporate Officer/Principal | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member | |
Imagen Biotech, Inc.
 Imagen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Imagen Biotech, Inc. develops therapeutics for sight-threatening diseases. The firm specializes in personalized chemotherapy, medicine, high content screening, cell biology and contract research. The company was founded by David R. Guyer and Matthew Feinsod in 2011 and is headquartered in New York, NY. | Pharmaceuticals: Major | President | |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Investment Managers | Private Equity Investor | |
| ALLAKOS INC. | Pharmaceuticals: Major | Chairman | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Biotechnology | Director/Board Member | |
| VAXCYTE, INC. | Biotechnology | Founder | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
Evommune, Inc.
 Evommune, Inc. Miscellaneous Commercial ServicesCommercial Services Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Fountain Therapeutics, Inc.
 Fountain Therapeutics, Inc. BiotechnologyHealth Technology Fountain Therapeutics, Inc. develops treatment for aging-associated diseases. The company is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 33 |
| Dänemark | 9 |
| Schweiz | 4 |
| Kanada | 3 |
| Deutschland | 2 |
Sektoral
| Health Technology | 34 |
| Consumer Services | 9 |
| Finance | 7 |
| Transportation | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 175 |
| Corporate Officer/Principal | 58 |
| Independent Dir/Board Member | 51 |
| Founder | 30 |
| Chief Executive Officer | 26 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Healy | 50 |
| Mahendra Shah | 34 |
| Kathy LaPorte | 34 |
| Edgar Engleman | 29 |
| Peter Moldt | 25 |
| Brian O'Callaghan | 20 |
| Nicole Onetto | 17 |
| Richard Miller | 13 |
| Frank Lee | 13 |
| Ashish Khanna | 12 |
| William Quinn | 11 |
| Randall Schatzman | 9 |
| Jason Pitts | 9 |
| Grant Yonehiro | 9 |
| Edith Perez | 9 |
- Börse
- Insiders
- Wesley Burwell
- Unternehmensverbindungen